(Circulation. 1999;99:2682-2687.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University (S.K., N.O., M.A., S.S., K.H., Y.S.); the Department of Restorative Neuromuscular Surgery and Rehabilitation, Tohoku University Graduate School of Medicine (Y.H.); and the Department of Thoracic and Cardiovascular Surgery, Tohoku University School of Medicine (S.K., K.T.), Sendai, Japan.
Correspondence to Yasufumi Sato, MD, PhD, Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, 4-1 Seiryomachi, Aoba-ku, Sendai, 980-8575, Japan. E-mail y-sato{at}idac.tohoku.ac.jp
| Abstract |
|---|
|
|
|---|
Methods and ResultsWhen cultured skeletal muscle cells were electrically stimulated at a voltage that did not cause their contraction, vascular endothelial growth factor (VEGF) mRNA was augmented at an optimal-frequency stimulation. This increase of VEGF mRNA was derived primarily from transcriptional activation. Electrical stimulation increased the secretion of VEGF protein into the medium. This conditioned medium then augmented the growth of endothelial cells. The effect of electrical stimulation was further confirmed in a rat model of hindlimb ischemia. The tibialis anterior muscle in the ischemic limb was electrically stimulated. The frequency of stimulation was 50 Hz and strength was 0.1 V, which was far below the threshold for muscle contraction. After a 5-day stimulation, there was a significant increase in blood flow within the muscle. Immunohistochemical analysis revealed that VEGF protein was synthesized and capillary density was significantly increased in the stimulated muscle. Rats tolerated this procedure very well, and there was no muscle contraction, muscle injury, or restriction in movement.
ConclusionsWe propose this procedure as a simple and practical method of therapeutic angiogenesis.
Key Words: electrical stimulation growth substances angiogenesis
| Introduction |
|---|
|
|
|---|
VEGF, a dimeric endothelial cell (EC)specific growth factor, is thought to be a principal angiogenic factor that stimulates migration, proliferation, and expression of various genes in ECs.8 9 10 VEGF is synthesized by cells around vasculature and affects ECs as a paracrine factor. The expression of VEGF is upregulated by hypoxia and various cytokines. Our present study revealed that low-voltage electrical stimulation of skeletal muscle induced de novo synthesis of VEGF protein, promoted local angiogenesis, and restored blood flow in the ischemic area. We propose this procedure as a simple and practical method of therapeutic angiogenesis.
| Methods |
|---|
|
|
|---|
Electrical Stimulation of Cells In Vitro
Before the following experiments, cells were preincubated for 24
hours in DMEM containing 0.1% BSA. Confluent cultures were
electrically stimulated at 1.0 V of stimulus strength and at indicated
frequencies (Hz) for an indicated period, according to the method
described by Brevet and Pinto.12
Northern Blot Analysis
Northern blot analysis was carried out as described
previously.13 Briefly, total RNA was extracted by the Acid
Guanidium-Phenol-Chloroform method and fractionated on a 1%
agarose gel containing 2.2 mol/L formaldehyde. The blots were then
prepared by transfer onto a nylon filter (Hybond
N+, Amersham). The filter was hybridized with a
32P-labeled probe in hybridization solution for
24 hours at 42°C. After the hybridization, the filter was washed in
2xSSC and 0.1% SDS at 60°C and then in 0.2xSSC and 0.1% SDS at
60°C. Autoradiography was carried out on an imaging
plate, and autoradiograms were analyzed with an
FLA 2000 image analyzer (Fuji). Human GAPDH cDNA templates were
prepared as previously described.13 Flk-1 and VEGF cDNA
templates were prepared by reverse-transcription polymerase chain
reaction using the following primer pairs: Flk-1: sense,
5'-AGGGGAACTGAAGACAGGCTA-3' and antisense,
5'-GATGCTCCAAGGTCAGGAAGT-3'; VEGF: sense,
5'-GTGCACTGGACCCTGGCTTT-3' and antisense,
5'-AAGCTGCCTCGCCTTGCAAC-3'.
Measurement of VEGF Protein in Conditioned Medium
C2C12 cells in DMEM containing 0.1% BSA were electrically
stimulated for 24 hours at 1.0 V and 50 Hz, and the medium was
collected. VEGF protein in the medium was measured by
Quantikine-M ELISA kit (R&D Systems) according to the manufacturer's
protocol.
Effect of Medium Conditioned by Electrical Stimulation on the
Growth of BCECs
BCECs (5x104) were plated on plastic
dishes in DMEM with 10% FCS and incubated for 6 hours to allow
attachment to the dish. The culture medium was replaced with either
100% conditioned medium, fresh medium (DMEM containing 0.1% BSA), or
fresh medium supplemented with 10 ng/mL of recombinant human VEGF. Cell
numbers were counted after 48 hours of incubation.
Electrical Stimulation In Vivo
All animal studies were performed according to a protocol
approved by the Animal Experiment Committee of our institution. Male
Sprague-Dawley rats (300 to 350 g body weight) were used. The
animals were anesthetized with light ether sedation and
subcutaneous injection of pentobarbital sodium (50 mg/kg) (Nembutal,
Abbott Laboratories). The operation for hindlimb ischemia was
performed according to the method described by Takeshita et
al.14 Briefly, the left femoral artery (FA) was completely
excised from its proximal origin to the point distally at which it
bifurcates into the saphenous and popliteal arteries. After 1 week was
allowed for recovery from the operation, blood flows of the bilateral
tibialis anterior (TA) muscles were measured by the hydrogen gas
clearance technique originally described by Aukland et
al15 and modified by Hori et al.16
Thereafter, the electrodes (Electrode for FES, Nihonseisen) were
implanted onto the fascia of the left TA muscle, tunneled
subcutaneously and exteriorized at the level of the
scapulae,17 and connected to a pulse generator (PulseCure,
OG Giken). Electrical stimulation was started on the day after
electrode implantation and continued for 5 days with a 0.3-ms stimulus
width, 50-Hz stimulus frequency, and 0.1-V stimulus strength, which was
far below the threshold of TA muscle contraction. The threshold of TA
muscle contraction in this experimental condition detected by
electromyogram was 1.1±0.2 V (data not shown). One day after the
period of electrical stimulation, animals were anesthetized,
blood flow was measured, and then the animals were killed for the
procurement of bilateral TA muscles for further evaluations.
Animals were divided into 3 groups. In the first group (5 animals), TA muscles were continuously stimulated for 5 days after the dissection and excision of the left FA. In the second group (4 animals), electrodes were implanted after the dissection and excision of the left FA, but TA muscles were not electrically stimulated. The third group (6 animals) received a sham operation of the left FA and no electrical stimulation despite the implantation of electrodes. The contralateral hindlimb of each animal served as the control.
Immunohistochemical Analysis
For detection of VEGF protein, muscle specimens were fixed with
10% formaldehyde, preincubated with 1% BSA for 30 minutes, and then
incubated with rabbit polyclonal anti-VEGF antibody (1
µg/mL) (Santa Cruz Biotechnology) for 30 minutes at room
temperature. Thereafter, the specimens were stained by the ABC method
(Elite, Vector Laboratories, Inc).
Determination of Capillary Density
Numbers of capillaries and muscle fibers were counted in at
least 8 different fields, and capillary density was obtained by the
calculation of capillary number/fiber area.
Calculations and Statistical Analysis
The statistical significance of differences in the results was
evaluated by use of unpaired ANOVA, and a value of P<0.05
was accepted as statistically significant.
| Results |
|---|
|
|
|---|
|
The level of expression of VEGF mRNA was determined by the
transcription rate of VEGF gene and/or the stability of VEGF mRNA.
Therefore, we used actinomycin-D (Act-D) to evaluate the stability of
VEGF mRNA. As shown in Figure 2
, the
half-lives of VEGF mRNA, which were calculated by drawing the best-fit
linear curve on a log-linear plot of the percentage of RNA remaining
versus time in Act-Dtreated cells, were 0.99 hour for electrically
stimulated and 1.12 hour without electrical stimulation. Thus,
the electrical stimulation did not affect the stability of VEGF mRNA,
indicating that the augmentation of VEGF mRNA by electrical stimulation
was at the transcriptional level.
|
Next, we examined the effect of transient electrical stimulation. Cells
were exposed to 2 hours of electrical stimulation, and then the total
RNA was harvested at 22 hours after the transient stimulation. The
results showed that the induction of VEGF mRNA was observed 22 hours
after the transient stimulation, and the level of its expression was
almost identical to that of the continuous electrical stimulation for
24 hours (Figure 3
). Because VEGF mRNA
returned to the basal level by 46 hours after a 2-hour electrical
stimulation, the second stimulation could increase VEGF mRNA to a level
comparable to the first stimulation. Thus, the transient electrical
stimulation was equally effective and was repeatable.
|
Synthesis and Secretion of VEGF Protein
The synthesis and secretion of VEGF protein into the medium was
analyzed by ELISA. VEGF in the medium of both C2C12 cells and
rat aortic smooth muscle cells was increased by electrical stimulation
(Figure 4A
). These stimulatory effects
were observed to increase VEGF mRNA at the same specific frequencies in
these cells. The elevation of VEGF protein in the medium was observed
as early as 12 hours and reached its peak at 48 hours (Figure 4B
).
The conditioned medium of electrical stimulation augmented
the growth of BCECs as much as the medium supplemented with 10 ng/mL of
human recombinant VEGF (Figure 4C
). Although proteins other than
VEGF might also be responsible for the growth of BCECs, the
concentration of VEGF in conditioned medium determined by ELISA
suggested that most of the effects on the growth of BCECs were derived
from VEGF.
|
Rat Model of Ischemic Hindlimb
We used the ischemic hindlimb animal model to investigate
whether electrical stimulation might induce angiogenesis and increase
blood flow in an ischemic limb. Blood flow was measured in TA
muscles of ischemic and contralateral limbs. The percentage of
blood flow in experimental muscles versus contralateral muscles is
shown in Figure 5
. Blood flow in the
ischemic limb on day 7 after the left FA excision was
significantly lower than that in the contralateral limb as well as in
the sham-operated animals. Whereas blood flow in the ischemic
limb on day 14 after the left FA excision did not increase without any
stimulation, continuous electrical stimulation significantly increased
blood flow in the TA muscle of the ischemic limb. In addition,
rats tolerated this procedure very well, and there was no muscle
contraction, muscle injury, or restriction in movement.
|
Immunostaining of TA muscles with polyclonal anti-VEGF
antibody revealed a significant increase of VEGF protein in the muscle
fibers of electrically stimulated TA muscles compared with unstimulated
muscles or contralateral TA muscles (Figure 6
). This increase of VEGF protein was
found only in the area between the electrodes on TA muscle. Capillary
density of the stimulated muscles was increased
2.5-fold compared
with the contralateral muscles, whereas unstimulated animals as well as
sham-operated animals had no significant difference between
ischemic and contralateral muscles (Figure 7
).
|
|
| Discussion |
|---|
|
|
|---|
Induction of angiogenesis in skeletal muscle by electrical stimulation has been described.21 22 23 24 25 However, the aim of electrical stimulation in those reports was to produce maximal muscle contraction. Indeed, they used an electrical strength of >2.0 V for the stimulation. It was hypothesized that hypoxia caused by muscle contraction was relevant to the increase of capillary density of skeletal muscles in their model.25 Nevertheless, strenuous electrical stimulation might be harmful, fail to restore blood flow, increase muscle atrophy, and worsen fatigue.26 Here, we used 0.1 V of electrical strength for stimulation of rat TA muscle. This strength of electrical stimulation was 10% of the threshold of muscle contraction and was well tolerated. We therefore propose that this procedure can be applicable as a simple and practical method of therapeutic angiogenesis.
Transcutaneous electrical nerve stimulation (TENS) has been used in the clinical field for pain control. Interestingly, TENS is highly effective in acute musculoskeletal pain as well as pain from peripheral vascular disease and from angina pectoris. However, the reasons for pain relief from TENS are largely unknown at present.27 Because TENS is primarily nerve stimulation and a high frequency in the range of 60 to 100 Hz is generally considered conventional for this treatment, it is not known whether conventional TENS induces regional angiogenesis.
Our results indicated that electrical stimulation augmented VEGF mRNA via transactivation of the VEGF gene. However, the mechanism of how low-voltage electrical stimulation induces the expression of VEGF gene is unknown. VEGF can be induced by various stimuli. Among them, hypoxia is thought to be one of the most important stimuli for the expression of the VEGF gene. Transactivation of the VEGF gene in hypoxia is mediated by hypoxia-inducible factor-1, which binds to the hypoxia responsible element in the 5' flanking region of the VEGF gene. Heme-containing protein works as a sensor of oxygen, and hypoxia, as well as nickel or cobalt, induces hypoxia-inducible factor-1 by activating this sensing system.28 We used nickel to mimic the hypoxic condition and found that the electrical stimulation reinforced the expression of VEGF in the hypoxic condition (data not shown). This notion is consistent with the in vivo experimental results showing that electrical stimulation effectively augmented VEGF synthesis in the ischemic skeletal muscle.
Gene therapy using VEGF is thought to be relevant for therapeutic angiogenesis, and a clinical trial is now progressing in the United States.7 However, gene therapy is not always available. The important point on this issue is that the expression of VEGF is not restricted to a specific cell type; rather, it is synthesized by a variety of cell types surrounding ECs. If one could force cells in the ischemic area to synthesize a sufficient amount of endogenous VEGF protein, synthesized VEGF would promote local angiogenesis and salvage the ischemic area. Our results reinforce the above idea. We propose that it would be valuable to consider this procedure for clinical application.
Received November 20, 1998; revision received February 2, 1999; accepted February 12, 1999.
| References |
|---|
|
|
|---|
2. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-dependent effect of basic fibroblast growth factor. J Vasc Surg. 1992;16:181191.[Medline] [Order article via Infotrieve]
3. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662670.
4. Hariwala M, Horowitz JR, Esakof D, Sheriff DD, Walter DH, Keyt B, Isner JM, Symes JF. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res. 1996;63:7782.[Medline] [Order article via Infotrieve]
5.
Banai S, Jaklitsch MT, Shou M, Lazarous DF, Schinomitz
M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of
collateral blood flow to ischemic myocardium by
vascular endothelial growth factor in dogs.
Circulation. 1994;89:21832189.
6.
Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T,
Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito
H. Salvage of infarcted myocardium by
angiogenic action of basic fibroblast growth factor.
Science. 1992;257:14011403.
7.
Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M,
Walsh K, Isner JM. Constitutive expression of
phVEGF165 after intramuscular gene transfer
promotes collateral vessel development in patients with critical limb
ischemia. Circulation. 1998;97:11141123.
8.
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara
N. Vascular endothelial growth factor is a secreted
angiogenic mitogen. Science. 1989;246:13061309.
9. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845848.[Medline] [Order article via Infotrieve]
10.
Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and
biological properties of the vascular endothelial
growth factor family of proteins. Endocrinol Rev. 1992;13:1832.
11. Sato Y, Shimada T, Takaki R. Autocrinological role of basic fibroblast growth factor on tube formation of vascular endothelial cells in vitro. Biochem Biophys Res Commun. 1991;180:10981102.[Medline] [Order article via Infotrieve]
12.
Brevet A, Pinto E. Myosin synthesis increased by
electrical stimulation of skeletal muscle cell cultures.
Science. 1976;193:11521154.
13. Iwasaka C, Tanaka K, Abe M, Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol. 1996;169:522531.[Medline] [Order article via Infotrieve]
14. Takeshita S, Isshiki T, Sato T. Increased expression of direct gene transfer into skeletal muscle observed after acute ischemic injury in rats. Lab Invest. 1996;74:10611065.[Medline] [Order article via Infotrieve]
15.
Aukland K, Bower BF, Berliner RW. Measurement of local
blood flow with hydrogen gas. Circ Res. 1964;14:164187.
16. Hori K, Zhang QH, Li HC, Saito S, Sato Y. Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow. Int J Cancer. 1996;65:360364.[Medline] [Order article via Infotrieve]
17.
Hang J, Kong L, Gu L, Adir TH. VEGF gene expression is
upregulated in electrically stimulated rat skeletal muscle.
Am J Physiol. 1995;269:H1827H1831.
18. Fitzsimmons RJ, Strong DD, Mohan S, Baylink D. Low-amplitude, low-frequency electric field-stimulated bone cell proliferation may in part be mediated by increased IGF-II release. J Cell Physiol. 1992;150:8489.[Medline] [Order article via Infotrieve]
19.
Kaye DM, Wiviott SD, Balligand JL, Simmons WW, Smith
TW, Kelly RA. Frequency-dependent activation of a constitutive nitric
oxide synthase and regulation of contractile function in adult rat
ventricular myocytes. Circ Res. 1996;78:217224.
20.
Annex BH, Torgan CE, Lin P, Taylor DA, Thompson MA,
Peters KG, Kraus WE. Introduction and maintenance of increased
VEGF protein by chronic motor nerve stimulation in skeletal muscle.
Am J Physiol. 1998;274:H860H867.
21. Brown MD, Cotter MA, Hudlicka O, Vrbova G. The effect of different patterns of muscle activity on capillary density, mechanical properties and structure of slow and fast rabbit muscles. Pflugers Arch. 1976;361:241250.[Medline] [Order article via Infotrieve]
22.
Hudlicka O, Tyler KR. The effect of long-term
intermittent high-frequency stimulation on capillary density and fibre
profiles in rabbit fast muscles. J Physiol. 1984;353:435445.
23. Hudlicka O, Fronek K. Effect of long-term electrical stimulation of rabbit fast muscles on the reactivity of their supplying arteries. J Vasc Res. 1992;29:1319.[Medline] [Order article via Infotrieve]
24.
Mathieu-Costello O, Agey PJ, Wu L, Hang J, Adair TH.
Capillary-to-fiber surface ratio in rat fast-twitch hindlimb muscle
after chronic electrical stimulation. J Appl Physiol. 1996;80:904909.
25. Hudlicka O, Price S. The role of blood flow and/or muscle hypoxia in capillary growth in chronically stimulated fast muscles. Pflugers Arch. 1990;417:6772.[Medline] [Order article via Infotrieve]
26.
Hudlicka O, Brown MD, Egginton S, Dawson JM. Effect of
long-term electrical stimulation on vascular supply and fatigue in
chronically ischemic muscles. J Appl Physiol. 1994;77:13171324.
27. Long DM. Fifteen years of transcutaneous electrical stimulation for pain control. Stereotact Funct Neurosurg. 1991;56:219.[Medline] [Order article via Infotrieve]
28.
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung
SW, Koos RD, Semenza GL. Activation of vascular
endothelial growth factor gene transcription by
hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:46044613.
This article has been cited by other articles:
![]() |
I. Sheikh, G. Tchekanov, D. Krum, J. Hare, M. Djelmami-Hani, R. Maddikunta, M. E. Mortada, P. Karakozov, I. Baibekov, J. Hauck, et al. Effect of Electrical Stimulation on Arteriogenesis and Angiogenesis after Bilateral Femoral Artery Excision in the Rabbit Hind-Limb Ischemia Model Vascular and Endovascular Surgery, May 1, 2005; 39(3): 257 - 265. [Abstract] [PDF] |
||||
![]() |
M. Inan, I. Alat, I. Gurses, E. Kekilli, R. Kutlu, A. Eskin, O. M. Aydin, H. Bostan, and S. Yologlu Induced angiogenesis with intramedullary direct current: experimental research Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H705 - H709. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bai, C. D. McCaig, J. V. Forrester, and M. Zhao DC Electric Fields Induce Distinct Preangiogenic Responses in Microvascular and Macrovascular Cells Arterioscler Thromb Vasc Biol, July 1, 2004; 24(7): 1234 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mycielska and M. B. A. Djamgoz Cellular mechanisms of direct-current electric field effects: galvanotaxis and metastatic disease J. Cell Sci., May 1, 2004; 117(9): 1631 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhao, H. Bai, E. Wang, J. V. Forrester, and C. D. McCaig Electrical stimulation directly induces pre-angiogenic responses in vascular endothelial cells by signaling through VEGF receptors J. Cell Sci., January 22, 2004; 117(3): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hiscock, C. P. Fischer, H. Pilegaard, and B. K. Pedersen Vascular endothelial growth factor mRNA expression and arteriovenous balance in response to prolonged, submaximal exercise in humans Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1759 - H1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chekanov, R. Rayel, D. Krum, I. Alwan, J. Hare, T. Bajwa, and M. Akhtare Electrical Stimulation Promotes Angiogenesis in a Rabbit Hind-Limb Ischemia Model Vascular and Endovascular Surgery, September 1, 2002; 36(5): 357 - 366. [Abstract] [PDF] |
||||
![]() |
S. Fuchs and R. Kornowski Transepicardial or transendocardial injury: controversies regarding angiogenic potential and mechanism of action Cardiovasc Res, February 16, 2001; 49(3): 582 - 587. [Full Text] [PDF] |
||||
![]() |
C. Patterson and M. S. Runge Therapeutic Angiogenesis : The New Electrophysiology? Circulation, May 25, 1999; 99(20): 2614 - 2616. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |